CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
MediGene AG Company Snapshot
MediGene AG operates in the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares MediGene AG with three other miscellaneous service companies in Europe: Medivir AB of Sweden (2016 sales of 93.04 million Swedish Kronor [US$11.41 million] of which 100% was Pharmaceutical), MaxCyte Inc of the United Kingdom (£9.13 million [US$12.04 million] of which 100% was Medical Service), and Inventiva SA which is based in France (9.45 million Euro [US$11.11 million] ).

Sales Analysis. MediGene AG reported sales of 9.75 million Euro (US$11.47 million) for the year ending December of 2016. This represents an increase of 43.2% versus 2015, when the company's sales were 6.81 million Euro. Despite this increase, sales are still well below the level achieved in 2014, when MediGene AG reported sales of 13.78 million Euro. Sales of Immunotherapies saw an increase that was more than double the company's growth rate: sales were up 8,675.0% in 2016, from 12,000.00 Euro to 1.05 million Euro.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
MediGene AG
  Stock Performance Chart for MediGene AG
 
  Stock Data: Recent Stock Performance:
  Current Price (10/13/2017): 12.82
(Figures in Euro)
1 Week -0.6%   13 Weeks 0.9%  
4 Weeks 17.0%   52 Weeks 28.3%  
 
MediGene AG Key Data:
  Ticker: MDG1 Country: Germany
  Exchanges: DUS Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2016 Sales 9,749,000
(Year Ending Jan 2017).
Employees: 88
  Currency: Euro Market Cap: 283,560,606
  Fiscal Yr Ends: December Shares Outstanding: 22,118,612
  Share Type: Namenaktie Closely Held Shares: 845,849
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.